Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
VT Samuel, GI Shulman - Cell metabolism, 2018 - cell.com
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery
The following position statement is issued by the American Society for Metabolic and
Bariatric Surgery in response to inquiries made to the society by patients, physicians, society …
Bariatric Surgery in response to inquiries made to the society by patients, physicians, society …
[HTML][HTML] Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und …
E Roeb, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …
Effects of fetuin-A with diverse functions and multiple mechanisms on human health
MA Icer, H Yıldıran - Clinical biochemistry, 2021 - Elsevier
Abstract Fetuin-A (Alfa 2-Heremans-Schmid) is a glycoprotein that is mainly synthesized by
hepatocytes and then released into the bloodstream. While fetuin-A, a multifunctional …
hepatocytes and then released into the bloodstream. While fetuin-A, a multifunctional …
Nutrition regulates innate immunity in health and disease
Nutrient content and nutrient timing are considered key regulators of human health and a
variety of diseases and involve complex interactions with the mucosal immune system. In …
variety of diseases and involve complex interactions with the mucosal immune system. In …
The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
SA Edwards‐Hampton, J Ard - Diabetes, Obesity and …, 2024 - Wiley Online Library
Obesity is a complex chronic disease with increasing prevalence across the globe. Medical
nutrition therapy (MNT) is an important component of obesity treatment, and low‐calorie …
nutrition therapy (MNT) is an important component of obesity treatment, and low‐calorie …
Effects of combined low‐dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non‐invasive indices of steatosis and fibrosis, and …
SA Polyzos, J Kountouras… - Diabetes, Obesity …, 2017 - Wiley Online Library
The beneficial effects of mineralocorticoid receptor blockade by spironolactone have been
shown in animal models of non‐alcoholic fatty liver disease (NAFLD). The aim of the present …
shown in animal models of non‐alcoholic fatty liver disease (NAFLD). The aim of the present …
[HTML][HTML] Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German Society of Gastroenterology, digestive and …
F Tacke, A Canbay, H Bantel, J Bojunga… - Zeitschrift für …, 2022 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …
Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
E Buzzetti, A Linden, LMJ Best… - Cochrane Database …, 2021 - cochranelibrary.com
Background The prevalence of nonalcohol‐related fatty liver disease (NAFLD) varies
between 19% and 33% in different populations. NAFLD decreases life expectancy and …
between 19% and 33% in different populations. NAFLD decreases life expectancy and …
[HTML][HTML] Effect of dietary intervention, with or without cointerventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: a systematic review and …
RL Hall, ES George, AC Tierney, AJ Reddy - Advances in Nutrition, 2023 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease from simple
steatosis to nonalcoholic steatohepatitis, with inflammatory cytokines and adipokines …
steatosis to nonalcoholic steatohepatitis, with inflammatory cytokines and adipokines …